Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?

There are minimal data regarding the management of high risk endometrial cancer histologies lacking invasive disease on the final pathology specimen. This study examines a cohort of these patients and assesses outcomes including time to recurrence and risk of death after management with and without...

Descripción completa

Detalles Bibliográficos
Autores principales: Mills, Kathryn A., Lopez, Heather, Sun, Lulu, Cripe, James C., Litz, Taylor, Thaker, Premal H., Powell, Matthew A., Mutch, David G., Fuh, Katherine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541758/
https://www.ncbi.nlm.nih.gov/pubmed/31193699
http://dx.doi.org/10.1016/j.gore.2019.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541758/
https://www.ncbi.nlm.nih.gov/pubmed/31193699
http://dx.doi.org/10.1016/j.gore.2019.05.007

Ejemplares similares